Suppr超能文献

RNA 甲基化调控因子相互作用与免疫浸润的综合分析及其在糖尿病肾病预测和个体化治疗中的应用。

Integrated analysis of RNA methylation regulators crosstalk and immune infiltration for predictive and personalized therapy of diabetic nephropathy.

机构信息

Research Institute of Nephrology, Zhengzhou University, Zhengzhou, 450052, People's Republic of China.

Traditional Chinese Medicine Integrated Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, People's Republic of China.

出版信息

Hum Genomics. 2023 Feb 10;17(1):6. doi: 10.1186/s40246-023-00457-9.

Abstract

BACKGROUND

RNA methylation is a widely known post-transcriptional regulation which exists in many cancer and immune system diseases. However, the potential role and crosstalk of five types RNA methylation regulators in diabetic nephropathy (DN) and immune microenvironment remain unclear.

METHODS

The mRNA expression of 37 RNA modification regulators and RNA modification regulators related genes were identified in 112 samples from 5 Gene Expression Omnibus datasets. Nonnegative Matrix Factorization clustering method was performed to determine RNA modification patterns. The ssGSEA algorithms and the expression of human leukocyte antigen were employed to assess the immune microenvironment characteristics. Risk model based on differentially expression genes responsible for the modification regulators was constructed to evaluate its predictive capability in DN patients. Furthermore, the results were validated by using immunofluorescence co-localizations and protein experiments in vitro.

RESULTS

We found 24 RNA methylation regulators were significant differently expressed in glomeruli in DN group compared with control group. Four methylation-related genes and six RNA regulators were introduced into riskScore model using univariate Logistic regression and integrated LASSO regression, which could precisely distinguish the DN and healthy individuals. Group with high-risk score was associated with high immune infiltration. Three distinct RNA modification patterns were identified, which has significant differences in immune microenvironment, biological pathway and eGFR. Validation analyses showed the METTL3, ADAR1, DNMT1 were upregulated whereas YTHDC1 was downregulated in DN podocyte cell lines comparing with cells cultured by the normal glucose.

CONCLUSION

Our study reveals that RNA methylation regulators and immune infiltration regulation play critical roles in the pathogenesis of DN. The bioinformatic analyses combine with verification in vitro could provide robust evidence for identification of predictive RNA methylation regulators in DN.

摘要

背景

RNA 甲基化是一种广泛存在的转录后调控方式,存在于许多癌症和免疫系统疾病中。然而,五种 RNA 甲基化调节剂在糖尿病肾病(DN)和免疫微环境中的潜在作用和相互作用仍不清楚。

方法

从 5 个基因表达综合数据集的 112 个样本中鉴定了 37 个 RNA 修饰调节剂和 RNA 修饰调节剂相关基因的 mRNA 表达。采用非负矩阵分解聚类方法确定 RNA 修饰模式。ssGSEA 算法和人类白细胞抗原的表达用于评估免疫微环境特征。基于负责修饰调节剂的差异表达基因构建风险模型,以评估其在 DN 患者中的预测能力。此外,通过体外免疫荧光共定位和蛋白质实验对结果进行验证。

结果

我们发现,与对照组相比,DN 组肾小球中 24 个 RNA 甲基化调节剂的表达显著不同。使用单变量 Logistic 回归和集成 LASSO 回归,将四个甲基化相关基因和六个 RNA 调节剂引入风险评分模型,可准确区分 DN 和健康个体。高风险评分组与高免疫浸润相关。鉴定出三种不同的 RNA 修饰模式,它们在免疫微环境、生物学途径和 eGFR 方面存在显著差异。验证分析表明,与在正常葡萄糖培养的细胞相比,DN 足细胞系中 METTL3、ADAR1、DNMT1 上调,而 YTHDC1 下调。

结论

我们的研究表明,RNA 甲基化调节剂和免疫浸润调节在 DN 的发病机制中起关键作用。生物信息学分析结合体外验证可为鉴定 DN 中具有预测性的 RNA 甲基化调节剂提供有力证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e18/9912588/1494425bb271/40246_2023_457_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验